Literature DB >> 35025031

F-box only protein 9 and its role in cancer.

Shujaat Hussain1,2,3,4,5, Jianshu Dong6,7,8,9,10, Xinli Ma11, Jian Li11, Shen Chen1,2,3,4,5, Agboybor Clement1,2,3,4,5, Hongmin Liu1,2,3,4,5.   

Abstract

The F-box proteins (FBP), substrate recognition subunit of the SCF (Skp1-Cullin1-F-box protein complex) E3 ligase, play important roles in the ubiquitylation and subsequent degradation of the target proteins from several cellular processes. Disorders of F-box protein-mediated proteolysis lead to human malignancies. FBP plays an important role in many cellular processes, including cell proliferation, cell cycle, apoptosis, migration, invasion, and metastasis, suggesting that it can be associated with tumorigenesis, cancer development and progression. However, the expression and function of FBXO9 (F-box only protein 9) differ in various types of human cancer. Due to the ability to regulate the stability and activity of oncogenes and tumor-suppressor genes, and the physiological functions of many of the F-box proteins remain subtle, further genetic and mechanistic studies will elaborate and help define FBXO9's role. Targeting F-box protein or F-box protein signaling pathways could be an effective strategy for preventing or treating human cancer. This review is presented to summarize the part of FBXO9 in different types of human cancer and its regulation mechanism, and to pave the way to design FBXO9-targeting anticancer therapies.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  E3 ubiquitin ligase; F-box only protein 9; F-box protein; Tumorigenesis; Ubiquitination

Mesh:

Substances:

Year:  2022        PMID: 35025031     DOI: 10.1007/s11033-021-07057-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  61 in total

Review 1.  The ubiquitin system, an immense realm.

Authors:  Alexander Varshavsky
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 2.  RING domain E3 ubiquitin ligases.

Authors:  Raymond J Deshaies; Claudio A P Joazeiro
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 3.  Proteostasis regulation by the ubiquitin system.

Authors:  John S Bett
Journal:  Essays Biochem       Date:  2016-10-15       Impact factor: 8.000

Review 4.  Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Authors:  Nana Zheng; Quansheng Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-05-05

Review 5.  Roles of F-box proteins in human digestive system tumors (Review).

Authors:  Jian Gong; Liang Lv; Jirong Huo
Journal:  Int J Oncol       Date:  2014-09-29       Impact factor: 5.650

6.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

Review 7.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 8.  The ubiquitin 26S proteasome proteolytic pathway.

Authors:  Jan Smalle; Richard D Vierstra
Journal:  Annu Rev Plant Biol       Date:  2004       Impact factor: 26.379

9.  Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling.

Authors:  Wei Li; Mario H Bengtson; Axel Ulbrich; Akio Matsuda; Venkateshwar A Reddy; Anthony Orth; Sumit K Chanda; Serge Batalov; Claudio A P Joazeiro
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more
  2 in total

1.  FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma.

Authors:  Zhenyu Wang; Xiaoxia Chen; Lianer Zhou; Xinge Zhao; Chao Ge; Fangyu Zhao; Haiyang Xie; Taoyang Chen; Hua Tian; Hong Li; Jinjun Li
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

2.  FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α /Cyclin D1 Axis in Ishikawa.

Authors:  Haoen Liu; Li Han; Liyan Zhong; Xiaodan Zhuang; Yan Peng
Journal:  J Immunol Res       Date:  2022-09-05       Impact factor: 4.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.